Terumo's Innovative Solutions for Blood and Cell Therapies Advancing Patient Care

in Tokyo as a thermometer manufacturer. Today, Terumo comprises three companies, generates more than $5.58 billion (about ¥820 billion) annually ... New Global Therapy Innovations business unit, led by Veerle d'Haenens, aims to unify therapeutic apheresis and cell and gene therapy expertise to expand ... Terumo Blood and Cell Technologies advances the adoption of automated manufacturing to bring novel cell and gene therapies to more Latin American patients. Terumo Blood and Cell Technologies (Terumo) and BioCentriq today announce the formation of a strategic collaboration designed to accelerate the adoption of ... Terumo BCT believes in the potential of blood to do even more for patients than it does today ... Terumo Blood and Cell Technologies•36K views. Learn about careers in #STEM (Science, Technology, Engineering, and Math) at Terumo Blood and Cell Technologies. Laura O'Boyle shares her ... Turning Hope into Reality: Unlocking the Potential of Blood and Cells. At Terumo Blood and Cell Technologies, we believe hope is concrete. Evidence-based ... This is our corporate video in #German. We are sharing our commitment to patients around the globe with our medical technologies that enable ... Terumo Blood and Cell Technologies' customers include blood centers, hospitals, therapeutic apheresis clinics, cell collection and processing ... Joy Duemke, North America director of marketing at Terumo Blood & Cell Technologies ... The expanding pipeline of cancer and rare disease ...